Histone deacetylase inhibition ameliorates hypertension and hyperglycemia in a model of Cushing's syndrome.

MLA

Hae-Ahm Lee, et al. “Histone Deacetylase Inhibition Ameliorates Hypertension and Hyperglycemia in a Model of Cushing’s Syndrome.” American Journal of Physiology: Endocrinology & Metabolism, vol. 314, no. 1, Jan. 2018, pp. E39–52. EBSCOhost, https://doi.org/10.1152/ajpendo.00267.2017.

APA

Hae-Ahm Lee, Seol-Hee Kang, Mina Kim, Eunjo Lee, Hyun-Min Cho, Eun-Kyung Moon, & Inkyeom Kim. (2018). Histone deacetylase inhibition ameliorates hypertension and hyperglycemia in a model of Cushing’s syndrome. American Journal of Physiology: Endocrinology & Metabolism, 314(1), E39–E52. https://doi.org/10.1152/ajpendo.00267.2017

Chicago

Hae-Ahm Lee, Seol-Hee Kang, Mina Kim, Eunjo Lee, Hyun-Min Cho, Eun-Kyung Moon, and Inkyeom Kim. 2018. “Histone Deacetylase Inhibition Ameliorates Hypertension and Hyperglycemia in a Model of Cushing’s Syndrome.” American Journal of Physiology: Endocrinology & Metabolism 314 (1): E39–52. doi:10.1152/ajpendo.00267.2017.